Skip to main content

Fuller & Thaler Asset Management, Inc.

Source: SEC Form 13F · as of Mar 2026

Fuller & Thaler Asset Management, Inc. holds 31 biotech & pharma companies tracked by BioSniper, totaling $1.72B in value as of Mar 2026 (SEC Form 13F).

Companies held

31

Total value held

$1.72B

BioSniper AIPage evidence connected

Prepared research question

What matters most for Jazz Pharmaceuticals plc (JAZZ)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.